Connect with us
Apply Now

Executive Voice

OmeCare is Providing Actionable Results for Prescription Medication with Their Proprietary Test Kits

Genetic testing has been a rapidly growing field over the past decade, and there are many companies that give consumers empty promises of being able to identify their genetic predisposition to a variety of different ailments, as well as optimize the use of prescription drugs. One of the few that is able to deliver actionable results, thanks to its proprietary methods and experienced team of scientists is OmeCare. The company is at the forefront of this genetic revolution. The company is based out of San Diego, California, and it is able to offer on-target results for consumers who want to optimize the effectiveness of their prescribed medication.

OmeCare offers a product called OmePsychiatricMed, which is able to ascertain the effectiveness of various antidepressants. Such medications include mood stabilizers, atypical antipsychotics, SSRI and TCA type, and a variety of other medications prescribed for mental health. With the ongoing pandemic, people have become more and more susceptible to emotions that require the use of anti-anxiety medication, sleep medication, as well as anti-depressants. The test offered by OmeCare offers a precise method to identify which types of medications are optimal for an individual, as the foundation of their work lies in the individualized genetic predisposition of each individual.

OmePsychiatricMed is an integral tool in providing in-depth analysis of how our body responds to various medications, giving both the patient and doctor much-needed analytics that can sustain optimal treatment of a patient’s condition, through the use of prescription medication. OmeCare distinguishes itself from other companies as it is able to offer an actionable response to over fifty different medications, as well as showing which enzymes of an individual is compatible with the respective medication. This has the effect to minimize any potential adverse side effects, giving the individual the optimal treatment version of whatever ailment they seek to cure. The OmePsychiatricMed report gives detailed analysis of results by applying the genetic markers of an individual as identified by their blood test. Then, it provides categories based on the alignment of the medication with the genetics of the individual- categories include, “Preferential Use”, “Use as Directed”, “May Have Significant Limitations”, and “May Cause Serious Adverse Events”.

Another great product offered by OmeCare is PaidMeds, it is able to identify which pain medications are of most utility to the patient, providing analysis which are beneficial for both the doctor and patient- in terms of which paid medication is most effective in alleviating pain, as well as the inherent adverse side effects ,as determined by the individual’s genetic predisposition. The report gives actionable results based on thirteen different paid medications and their chemicals, which gives the individual knowledge about how their body metabolizes the drug. This leads to optimal results because the report identifies potential side-effects that can be life-threatening, adverse, or simply unpleasant.

OmeCare is vastly different from its competitors because of its proprietary systems that are able to precisely identify genetic markers, and apply the effect of a substance on personalized level. Each report assigns a score based on its scientific foundation, and does so with impeccable accuracy. Both tests can be done from the comfort of an individual’s home, using a simple cheek swab saliva test. The accuracy and precision of OmeCare, as well as its proprietary technology, is what separates this genetic company from the rest.

For more info, please check out www.omecare.co

Continue Reading

Copyright © 2022 Disrupt ™ Magazine is a Minority Owned Privately Held Company - Disrupt ™ was founder by Puerto Rican serial entrepreneur and philanthropist Tony Delgado who is on a mission to transform Latin America using the power of education and entrepreneurship.

Disrupt ™ Magazine
151 Calle San Francisco
Suite 200
San Juan, Puerto Rico, 00901

Opinions expressed by Disrupt Contributors are their own. Disrupt Magazine invites voices from many diverse walks of life to share their perspectives on our contributor platform. We are big believers in freedom of speech and while we do enforce our community guidelines, we do not actively censor stories on our platform because we want to give our contributors the freedom to express their opinions. Articles are not commissioned by our editorial team, and opinions expressed by our community contributors do not reflect the opinions of Disrupt or its employees.
We are committed to fighting the spread of misinformation online so if you feel an article on our platform goes against our community guidelines or contains false information, we do encourage you to report it. We need your help to fight the spread of misinformation. For more information please visit our Contributor Guidelines available here.

Disrupt ™ is the voice of latino entrepreneurs around the world. We are part of a movement to increase diversity in the technology industry and we are focused on using entrepreneurship to grow new economies in underserved communities both here in Puerto Rico and throughout Latin America. We enable millennials to become what they want to become in life by learning new skills and leveraging the power of the digital economy. We are living proof that all you need to succeed in this new economy is a landing page and a dream. Disrupt tells the stories of the world top entrepreneurs, developers, creators, and digital marketers and help empower them to teach others the skills they used to grow their careers, chase their passions and create financial freedom for themselves, their families, and their lives, all while living out their true purpose. We recognize the fact that most young people are opting to skip college in exchange for entrepreneurship and real-life experience. Disrupt Magazine was designed to give the world a taste of that.